BRPI0818674A2 - Método para produção de anticorpos - Google Patents

Método para produção de anticorpos

Info

Publication number
BRPI0818674A2
BRPI0818674A2 BRPI0818674-0A2A BRPI0818674A BRPI0818674A2 BR PI0818674 A2 BRPI0818674 A2 BR PI0818674A2 BR PI0818674 A BRPI0818674 A BR PI0818674A BR PI0818674 A2 BRPI0818674 A2 BR PI0818674A2
Authority
BR
Brazil
Prior art keywords
antibody production
antibody
production
Prior art date
Application number
BRPI0818674-0A2A
Other languages
English (en)
Inventor
Yoshiki Yamada
Tatsuya Kiyasu
Kazuyuki Tabata
Akihiro Kuzumaki
Mai Yamashiro
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0818674(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of BRPI0818674A2 publication Critical patent/BRPI0818674A2/pt
Publication of BRPI0818674B1 publication Critical patent/BRPI0818674B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BRPI0818674-0A 2007-10-15 2008-10-14 Métodos para produção de um anticorpo inteiro ou de um fragmento do mesmo e para preparação de fármacos, bem como vetor recombinante BRPI0818674B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2007-267384 2007-10-15
JP2007267384 2007-10-15
JP2008103308 2008-04-11
JP2008-103308 2008-04-11
PCT/JP2008/068588 WO2009051108A1 (ja) 2007-10-15 2008-10-14 抗体の製造方法

Publications (2)

Publication Number Publication Date
BRPI0818674A2 true BRPI0818674A2 (pt) 2014-10-14
BRPI0818674B1 BRPI0818674B1 (pt) 2023-01-17

Family

ID=40567372

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818674-0A BRPI0818674B1 (pt) 2007-10-15 2008-10-14 Métodos para produção de um anticorpo inteiro ou de um fragmento do mesmo e para preparação de fármacos, bem como vetor recombinante

Country Status (17)

Country Link
US (3) US9683027B2 (pt)
EP (1) EP2202307B2 (pt)
JP (4) JP4976502B2 (pt)
KR (1) KR101558009B1 (pt)
CN (3) CN103540632A (pt)
AU (1) AU2008312937B2 (pt)
BR (1) BRPI0818674B1 (pt)
CA (1) CA2701338C (pt)
DK (1) DK2202307T4 (pt)
ES (1) ES2499391T5 (pt)
IL (2) IL205051A (pt)
MX (1) MX2010004007A (pt)
PL (1) PL2202307T5 (pt)
SG (1) SG185302A1 (pt)
SI (1) SI2202307T2 (pt)
TW (1) TWI463010B (pt)
WO (1) WO2009051108A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2202307T5 (pl) 2007-10-15 2021-10-04 Chugai Seiyaku Kabushiki Kaisha Sposób wytwarzania przeciwciała
US20110117087A1 (en) 2009-10-26 2011-05-19 Reinhard Franze Method for the production of a glycosylated immunoglobulin
MY163081A (en) * 2010-12-28 2017-08-15 Chugai Pharmaceutical Co Ltd Animal cell culturing method
CA2903589A1 (en) * 2013-03-15 2014-09-18 Genentech, Inc. Cell culture media and methods of antibody production
JP6563910B2 (ja) 2013-07-04 2019-08-21 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 血清サンプル中の抗薬物抗体を検出するための干渉抑制イムノアッセイ
US20190225694A1 (en) 2016-06-28 2019-07-25 Zaklady Farmaceutyczne Polpharma Sa Recombinant production of monoclonal antibodies
EP3541413A2 (en) 2016-11-21 2019-09-25 Polpharma Biologics S.A. Aqueous pharmaceutical formulations
WO2025134341A1 (ja) 2023-12-22 2025-06-26 中外製薬株式会社 抗体の製造方法
WO2025141786A1 (ja) 2023-12-27 2025-07-03 中外製薬株式会社 抗体の製造方法
WO2025232879A1 (en) 2024-05-10 2025-11-13 Cytocares (Shanghai) Inc. Anti-lilrb2 monospecific and bispecific antibody constructs and uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPS6459878A (en) 1987-08-31 1989-03-07 Matsushita Electric Industrial Co Ltd Semiconductor laser protective circuit
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ES2139598T3 (es) 1990-07-10 2000-02-16 Medical Res Council Procedimientos para la produccion de miembros de parejas de union especifica.
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
CA2090969C (en) † 1990-09-04 2001-08-21 Russell Arthur Brierley Production of insulin-like growth factor-1 in methylotrophic yeast cells
AU668349B2 (en) * 1991-04-25 1996-05-02 Chugai Seiyaku Kabushiki Kaisha Reconstituted human antibody against human interleukin 6 receptor
JP3540315B2 (ja) 1991-09-23 2004-07-07 メディカル リサーチ カウンシル キメラ抗体の製造−組合せアプローチ
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
JPH07503132A (ja) 1991-12-17 1995-04-06 ジェンファーム　インターナショナル，インコーポレイティド 異種抗体を産生することができるトランスジェニック非ヒト動物
EP0656941B1 (en) 1992-03-24 2005-06-01 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
ES2301158T3 (es) 1992-07-24 2008-06-16 Amgen Fremont Inc. Produccion de anticuerpos xenogenicos.
AU6819494A (en) 1993-04-26 1994-11-21 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
GB9313509D0 (en) 1993-06-30 1993-08-11 Medical Res Council Chemisynthetic libraries
CA2177367A1 (en) 1993-12-03 1995-06-08 Andrew David Griffiths Recombinant binding proteins and peptides
US5531053A (en) 1994-06-14 1996-07-02 Hamm; Hans Spring fastener for holding insulation against an inner surface of cavity walling
ATE340590T1 (de) 1994-07-13 2006-10-15 Chugai Pharmaceutical Co Ltd Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
US5561053A (en) 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP0985033A4 (en) * 1997-04-04 2005-07-13 Biosite Inc POLYVALENT AND POLYCLONAL LIBRARIES
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
EP0979281B1 (en) 1997-05-02 2005-07-20 Genentech, Inc. A method for making multispecific antibodies having heteromultimeric and common components
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
EP1383800A4 (en) † 2001-04-02 2004-09-22 Idec Pharma Corp RECOMBINANT ANTIBODIES CO-EXPRESSED WITH GNTIII
US6605176B2 (en) 2001-07-13 2003-08-12 Taiwan Semiconductor Manufacturing Co., Ltd. Aperture for linear control of vacuum chamber pressure
US20030157641A1 (en) * 2001-11-16 2003-08-21 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
ATE420964T1 (de) 2001-11-16 2009-01-15 Biogen Idec Inc Polycistronische expression von antikörpern in cho zellen
EP2204190A1 (en) 2003-07-15 2010-07-07 Chugai Seiyaku Kabushiki Kaisha IgM production by transformed cells and methods for quantifying said IgM production
EP1733034A4 (en) * 2004-03-15 2010-01-20 Biogen Idec Inc METHOD AND CONSTRUCTS FOR THE EXPRESSION OF POLYPEPTIDE MULTIMERS IN EUKARYONTIC CELLS USING ALTERNATIVE SPLEISSEN
AU2005256113B2 (en) 2004-07-09 2011-02-10 Chugai Seiyaku Kabushiki Kaisha Anti-glypican 3 antibody
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
CN101595228A (zh) * 2005-07-21 2009-12-02 艾博特公司 包括sorf构建体的多基因表达和使用多蛋白、前体蛋白和蛋白酶解的方法
PL2202307T5 (pl) * 2007-10-15 2021-10-04 Chugai Seiyaku Kabushiki Kaisha Sposób wytwarzania przeciwciała

Also Published As

Publication number Publication date
DK2202307T4 (da) 2021-10-04
PL2202307T5 (pl) 2021-10-04
JP5788830B2 (ja) 2015-10-07
EP2202307A4 (en) 2012-01-25
TW200934867A (en) 2009-08-16
CN101802192A (zh) 2010-08-11
JP6092304B2 (ja) 2017-03-08
SI2202307T2 (sl) 2021-11-30
JP2012143246A (ja) 2012-08-02
IL240122A0 (en) 2015-09-24
KR20100074184A (ko) 2010-07-01
SI2202307T1 (sl) 2014-11-28
US9683027B2 (en) 2017-06-20
JP4976502B2 (ja) 2012-07-18
CA2701338A1 (en) 2009-04-23
DK2202307T3 (da) 2014-09-15
US20210300996A1 (en) 2021-09-30
CA2701338C (en) 2018-09-18
ES2499391T3 (es) 2014-09-29
BRPI0818674B1 (pt) 2023-01-17
TWI463010B (zh) 2014-12-01
JP2015198663A (ja) 2015-11-12
IL205051A (en) 2015-09-24
MX2010004007A (es) 2010-06-15
AU2008312937B2 (en) 2015-01-22
JPWO2009051108A1 (ja) 2011-03-03
PL2202307T3 (pl) 2015-02-27
JP6506786B2 (ja) 2019-04-24
KR101558009B1 (ko) 2015-10-19
WO2009051108A1 (ja) 2009-04-23
US20170275351A1 (en) 2017-09-28
EP2202307A1 (en) 2010-06-30
EP2202307B2 (en) 2021-07-14
AU2008312937A1 (en) 2009-04-23
IL205051A0 (en) 2010-11-30
US20100291627A1 (en) 2010-11-18
CN106244651A (zh) 2016-12-21
IL240122B (en) 2019-02-28
EP2202307B1 (en) 2014-08-20
US11136375B2 (en) 2021-10-05
US12145978B2 (en) 2024-11-19
SG185302A1 (en) 2012-11-29
JP2017079794A (ja) 2017-05-18
ES2499391T5 (es) 2021-12-22
CN103540632A (zh) 2014-01-29

Similar Documents

Publication Publication Date Title
BRPI0917145A2 (pt) Método para fabricar biocombustíveis
BRPI0719843A2 (pt) Método para a produção de bisbenzoxazóis
BRPI0922490A2 (pt) Método para produção de beta-santaleno
PL2155838T3 (pl) Sposób wytwarzania węglowodorów rozgałęzionych
BRPI0817836A2 (pt) Método para a produção de cerveja
CR10705A (es) Anticuerpos para linfotoxina-alfa
PT2853545T (pt) Anticorpo específico para ige
BRPI0821158A2 (pt) Método para fazer lentes de contato
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
BR112012002746A2 (pt) método para produção de copolímero
PL2155839T3 (pl) Sposób wytwarzania węglowodorów rozgałęzionych
BRPI0819337A2 (pt) Método para produção de glicinatos de acila
BRPI0819238A2 (pt) Métodos para a produção de caseína
FI20075721L (fi) Menetelmä pyrolysoinnin toteuttamiseksi
BRPI0910454A2 (pt) processo para produção de uma proteína policlonal
BRPI0815550A2 (pt) Método para estabilizar fenilefrina
BRPI0813858A2 (pt) Método para produzir peptídeo
FI20075505L (fi) Menetelmä silmälasien valmistamiseksi
BRPI1007459A2 (pt) método para produção de manômeros olefínicos
BRPI0812741A2 (pt) Método para separação de glóbulos
BRPI0813960A2 (pt) Processo para produção de biarilas
BRPI0914680A2 (pt) método para produção de dispositivos de distribuição
BRPI0918633A2 (pt) método para calcinar matérias-primas.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/10/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.